Skip to main content
Clinical Trials/NCT05129358
NCT05129358
Completed
Not Applicable

Testing of an Electronic Patch During Dehydration in Healthy Volunteers

Mode Sensors AS1 site in 1 country31 target enrollmentMay 30, 2022

Overview

Phase
Not Applicable
Intervention
Dehydration
Conditions
Dehydration
Sponsor
Mode Sensors AS
Enrollment
31
Locations
1
Primary Endpoint
Change in impedance following mild dehydration
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this study is to investigate the ability of a wearable bioimpedance sensor to detect mild dehydration in healthy volunteers following the administration of Furosemide. In addition, the study will investigate changes in bioimpedance related to normal variation in tissue hydration (circadian changes, skin thickness, posture, and moderate activity). The study will also provide information on the durability of the sensor.

Detailed Description

The subjects will use the patches for ten days. During the ten-day period, subjects are exposed to an intervention on day 2 or 3 while being monitored by health personnel: * Subjects are given a diuretic (Furosemide) and monitored for two hours without any intake. * The intervention is followed by intake of a rehydration solution (up to 1500 ml), containing glucose and electrolytes (Resorb Sport, Nestle S.A.).

Registry
clinicaltrials.gov
Start Date
May 30, 2022
End Date
November 3, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • BMI: 18-30
  • Age: 18-60
  • Willing to refrain from exercise for the duration of the study
  • Willing to refrain from bathing, swimming and other physical activity causing considerable sweating/movement (e.g. cycling, mountain hiking, climbing)

Exclusion Criteria

  • Hypersensitivity to diuretics
  • Hypotension or orthostatic hypotension
  • Urinary retention
  • Pregnancy or breast feeding
  • Allergy to medical adhesive or gel
  • Any planned medical examination during the intervention period
  • Pacemaker
  • Use of medication with a significant impact on the body's fluid balance, such as diuretic

Arms & Interventions

Hydration sensor

The subjects use the wearable hydration sensor for ten days and undergo a dehydration/rehydration intervention on day 2 or 3.

Intervention: Dehydration

Hydration sensor

The subjects use the wearable hydration sensor for ten days and undergo a dehydration/rehydration intervention on day 2 or 3.

Intervention: Rehydration

Outcomes

Primary Outcomes

Change in impedance following mild dehydration

Time Frame: 2 hours

Relative change in extracellular resistance measured by the investigational device following administration of Furosemide compared to control days

Secondary Outcomes

  • Change in impedance following rehydration(1 hour)

Study Sites (1)

Loading locations...

Similar Trials